Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Inflazyme and Helicon to study drug leads related to learning and memory

Feb. 9, 2001

Elan identifies new tetrapeptides that inhibit beta-secretase

Feb. 8, 2001

AstraZeneca prepares analgesics interacting with I2 receptors or sodium channels

Feb. 8, 2001

Organon's antidepressant Remeron SolTab launched in U.S., copromotion of drug with Solvay reported

Feb. 8, 2001

Lundbeck seeks first approval of Cipralex in Sweden

Feb. 8, 2001

Rhodanine derivatives inhibit amyloid protein aggregation, image amyloid deposits

Feb. 7, 2001

New compounds from Toyama as remedies for neurodegenerative disorders

Feb. 7, 2001

Preparation and use of new brain GABA receptor ligands

Feb. 7, 2001

DHA-clozapine appears to have enhanced efficacy and safety compared to clozapine

Feb. 7, 2001

High-dose Rebif recommended for early first-line treatment of relapsing-remitting MS

Feb. 7, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...